NCT04747912
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University of Chicago Medical Center Chicago, Illinois, United States
Clinical trial condition
Lymphoblastic Leukemia
Explore clinical trials studying Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.
22 public trials
8 recruiting studies
Lymphoblastic Leukemia trial results
NCT05848687
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Valley Children's Hospital Madera, California, United States
NCT06207123
- Conditions
- Acute Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
- University of Rochester Medical Center, Wilmot Cancer Center Rochester, New York, United States
NCT05194397
- Conditions
- Anemia, Anemia, Aplastic, Aplastic Anemia, +27 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT06961669
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +25 more
- Locations
-
- The First Affiliated Hospital of University of Science and Technology of China Hefei, China
NCT05648019
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR, +28 more
- Locations
-
- Singapore General Hospital Singapore
- KK Women's and Children's Hospital Singapore
NCT05043571
- Conditions
- CAR, CAR T-Cell-Related Encephalopathy Syndrome, Hematologic Diseases, +16 more
- Locations
-
- Allen Yeoh Eng Juh Singapore
Recruiting
ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.
NCT05038696
- Conditions
- CAR, CAR T-Cell-Related Encephalopathy Syndrome, Hematologic Diseases, +14 more
- Locations
-
- Allen Yeoh Eng Juh Singapore
Not Yet Recruiting
A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia
NCT07283640
- Conditions
- Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- MD Anderson Cancer Houston, Texas, United States
NCT07178912
- Conditions
- Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States